MATCH SIZE AND QUANTITY
Build your comparison.
Choose a labeled amount and selection to load matching prices.
Product comparison
Compare Selank Atomized Solution Kit listings by strength, selection and supplier. Inspect the original source behind each price.
MATCH SIZE AND QUANTITY
Choose a labeled amount and selection to load matching prices.
GO BEYOND THE PRICE
Select a strength and selection above to view price history, save a price watch or add it to your basket.
DOCUMENTATION PASSPORTS
Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.
Loading documentation records…
Comparable quantities are not established for these source-defined selections. Inspect the original listing before comparing.
Reported quantities in this family: not established. Counts and units must be matched to the exact listing.
Choose the labeled amount per unit and quantity before comparing. A single unit and a multipack have different upfront prices. Keep product format and exact recipe consistent; similar names do not establish equivalent products.
Follow the original listing to check its quantity, availability and current price. 1 listing in this family have incomplete quantity details and receive no inferred per-mg price.

153 products · 275 listings
1 listing from direct supplier captures. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.
Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.
FROM PEPTIDES CALCULATOR
Source profile reviewed 2026-10-01 · Imported 2026-10-22. Read the full compound profile
Selank is a synthetic seven-residue peptide designed at the Institute of Molecular Genetics of the Russian Academy of Sciences by attaching the proline-glycine-proline tripeptide to the immune peptide tuftsin, which slows enzymatic breakdown. It is registered in Russia as Selank 0.15% nasal drops, an over-the-counter anxiolytic under registration number LRS-003338/09, and is classified there as a tranquilliser rather than a supplement. Human evidence is limited to a small number of Russian-language trials in anxiety, phobic and somatoform disorders, mostly comparing it with benzodiazepines in groups of 60 to 70 patients; it has no FDA or EMA approval and is sold elsewhere as a research chemical. Western community use frequently adopts subcutaneous injection, a route with no registered product and no human protocol in the indexed literature.
A 62-patient study compared Selank with medazepam and reported similar anxiety-scale improvement.
Rat frontal-cortex studies found broad transcriptional changes after Selank administration.
Modern, preregistered, multicenter trials outside the originating network are lacking.
Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.